FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention describes compound of the formula (I) or its pharmaceutically acceptable salt, or an enantiomer wherein n = 0 or 1; a - b means -CF=CH or -CHFCH2; R1 represents (C1-C3)-alkyl wherein alkyl is unsubstituted; R2 represents hydrogen atom; R3 is chosen from (C1-C4)-alkyl, (CH2)n-cycloheteroalkyl and (CH2)n-aryl; or R2 and R3 form in common 6-membered saturated ring condensed with 5-membered aromatic ring system comprising 2 heteroatoms chosen from nitrogen atom (N), and pharmaceutical compositions. Compounds of the formula (I) represent modulators of androgen receptors (AR) possessing tissue-selective effect. Proposed compounds are useful as androgen receptors agonists in osseous and/or muscle tissue in antagonizing AR in male patient prostate or in female patient uterus.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
36 cl, 2 tbl, 72 ex
Title |
Year |
Author |
Number |
FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION |
1993 |
- Akille Pantseri
- Marchella Nesi
- Ehnriko Di Salle
|
RU2125061C1 |
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE |
1992 |
- Glenn Dzh.Gomlej
- Ehlizabet Stoner
|
RU2125879C1 |
ANDROSTEN(ANE) (ONE) DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF, METHODS OF PREPARATION THEREOF, AND METHOD OF MEDICAL TREATMENT |
1994 |
- Behchelor Kennet Uil'Jam
- Fraj Stiven Vernon
|
RU2144037C1 |
METHODS OF SYNTHESIS OF AZASTEROID DERIVATIVES, DERIVATIVE OF AZASTEROID-IMIDAZOLIDE, METHOD OF ITS SYNTHESIS |
1998 |
- Pantseri Akille
- D'Anello Matteo
- Longo Antonio
- Nesi Marchella
|
RU2198176C2 |
INHIBITORS OF TESTOSTERONE 5α-REDUCTASE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TESTOSTERONE 5α-REDUCTASE ACTIVITY |
1993 |
- Fernand Labri
- Iv Meran
- Shankar M.Singkh
|
RU2141967C1 |
HALOGEN- AND PSEUDOHALOGEN-SUBSTITUTED 17-METHYLENE-4-AZASTEROIDS, THEIR USING, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION |
2002 |
- Mentsenbakh Bernd
- Dresher Peter
- Khillish Aleksander
- Ehl'Ger Val'Ter
- Shvajkert Khans-Udo
- Shell'Kopf Klaus
|
RU2293740C2 |
SPECIFIC GLYCOCOTRICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT |
2004 |
- Biggadajk Kejt
- Dzhon Meht'Ju Piter
- Nidkham Debora
|
RU2348645C2 |
ANTIANDROGENIC COMPOUNDS, PRECURSOR OF ANTIANDROGENIC COMPOUND, PHARMACEUTICAL COMPOSITIONS |
1993 |
- Fernand Labri
- Iv Merand
- Shankar M.Singkh
|
RU2141966C1 |
16α-BROMO-3β-HYDROXY-5α-ANDROSTANE-17-ONE SEMIHYDRATE, METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITIONS, USING COMPOUNDS |
2000 |
- Alem Klarens Nataniehl
- Frinke Dzhejms Martin
- De Karval'O Luis Daniehl' Dos Ankhos
- Khehggi Vil'Jam
- Prendergast Patrik T.
- Riding Kristofer L.
- Tadikonda Krupakar Pol
- Vernon Rassehl' Nehjl
|
RU2295534C2 |
COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF PROSTATE CANCER |
1998 |
- Kodzima Koiti
- Kobajasi Tomovo
|
RU2196582C2 |